CGT · 위암

22개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved22 programs
CGTLimited DatastaleOno Pharmaceutical Co., Ltd.Phase 3

tegafur-gimeracil-oteracil potassium (tegafur-gimeracil-oteracil potassium)

Gastric Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Phase3#Popular#cell-gene-therapy+5
Trials 54Status Recruiting
CGTLimited DatastaleAlaunos TherapeuticsPreclinical

autologous activated T lymphocyte (autologous activated T lymphocyte)

Relapsed or Advanced Gastric Adenocarcinoma; Gastro-esophageal Junction Cancer · Relapsed or Advanced Gastric Adenocarcin

#RelapsedorAdvancedGastricAdenoca#CGT#Preclinical#Popular#cell-gene-therapy+5
Trials 51Status Active
CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 2

CEA-targeted CAR-T cells (CEA-targeted CAR-T cells)

Gastric Cancer; Colon Cancer · CEA

#CEA#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 19Status Active
CGTLimited DatastaleM.D. Anderson Cancer CenterPhase 2

TGFBR2 KO CAR27/IL-15 NK cells (TGFBR2 KO CAR27/IL-15 NK cells)

Gastric Cancer, Metastatic · Lymphoid

#Lymphoid#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 4Status Recruiting
CGTLimited DatastaleBeijing BiotechPhase 2

EB-DT-CAR-NK (EB-DT-CAR-NK)

Advanced Gastric Adenocarcinoma; Advanced Gastroesophageal Junction Adenocarcinoma · Advanced Gastric Adenocarcinoma

#AdvancedGastricAdenocarcinoma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 3Status Recruiting
CGTLimited DatastaleBeijing Immunochina Medical Sci…Phase 1

IM96 CAR-T cells (IM96 CAR-T cells)

Adenocarcinoma of Gastric; Adenocarcinoma of Esophagogastric Junction · Advanced Solid Tumors

#AdvancedSolidTumors#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Recruiting
CGTLimited DatastaleCARsgen Therapeutics Co., Ltd.Preclinical

CAR-CLD18 T Cells (CAR-CLD18 T Cells)

Advanced Gastric Adenocarcinoma; Pancreatic Adenocarcinoma · Advanced Gastric Adenocarcinoma

#AdvancedGastricAdenocarcinoma#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 2Status Active
CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 1

Intraperitoneal infusion of FAST CEA-targeted CAR-T (Intraperitoneal infusion of FAST CEA-targeted CAR-T)

Colorectal Cancer; Stomach Cancer · CEA

#CEA#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleIovance Biotherapeutics, Inc.Phase 1

KK-LC-1 TCR-T cells (KK-LC-1 TCR-T cells)

Gastric Cancer; Breast Cancer · Gastric Cancer

#GastricCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleNational Cancer Institute (NCI)Phase 2

Anti-KRAS G12V mTCR PBL (Anti-KRAS G12V mTCR PBL)

Pancreatic Cancer; Gastric Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleCARsgen Therapeutics Co., Ltd.Phase 1

CAR-CLDN18.2 T-Cells (CAR-CLDN18.2 T-Cells)

Advanced Solid Tumor · CLDN18.2

#CLDN182#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleZhejiang Provincial People's Ho…Phase 1

CB CAR-NK18.2 (CB CAR-NK18.2)

Gastric Cancer; Pancreas Adenocarcinoma · Gastric Cancer

#GastricCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleFirst Affiliated Hospital of We…Phase 1

CBG131 CAR-T Cell Infusion (CBG131 CAR-T Cell Infusion)

Advanced Gastric and Pancreatic Cancer · Advanced Gastric and Pancreatic Cancer

#AdvancedGastricandPancreaticCanc#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleSuzhou Immunofoco Biotechnology…Phase 1

Claudin 18.2 CAR-T (Claudin 18.2 CAR-T)

Gastric Cancer; Pancreatic Cancer · Gastric Cancer

#GastricCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleShenzhen University General Hos…Preclinical

Claudin18.2 CAR-T cells (Claudin18.2 CAR-T cells)

Advanced Pancreatic Carcinoma; Advanced Gastric Carcinoma · Advanced Pancreatic Carcinoma

#AdvancedPancreaticCarcinoma#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleSichuan UniversityPhase 1

Dual-targeting CLDN18.2 and PD-L1 CAR-T cells (Dual-targeting CLDN18.2 and PD-L1 CAR-T cells)

Advanced Solid Tumor · PD-L1

#PD-L1#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleBeijing BiotechPhase 2

CLDN18.2 + MUC1 (EB-DNK102 dual-targeting CAR-NK cells, EB-DNK102 dual-targeting CAR-NK cells (CLDN18.2 + MUC1))

Pancreatic Ductal Adenocarcinoma (PDAC); Unresectable Locally Advanced or Metastatic Disease · CLDN18.2

#CLDN182#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleSinobioway Cell Therapy Co., Lt…Preclinical

EPCAM-targeted CAR-T cells (EPCAM-targeted CAR-T cells)

Stomach Neoplasms · Liver Neoplasms

#LiverNeoplasms#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleNanjing Legend Biotech Co.Phase 1

LCAR-C182A cells (LCAR-C182A cells)

Gastric Cancer; Pancreatic Ductal Adenocarcinoma · Gastric Cancer

#GastricCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
CGTLimited Datastalejiuwei cuiPhase 1

PD-1-M1-NK Cells (PD-1-M1-NK Cells)

Advanced Gastric or Colorectal Cancer · PD-1

#PD-1#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting

1 / 2 pages

← PreviousNext →